UroLift is a breakthrough minimally invasive procedure that provides rapid relief for an enlarged prostate, also known as benign prostatic hyperplasia (BPH). It uses tiny implants to gently pull back excess prostate tissue and open up the urethra.
The UroLift procedure is performed in an outpatient setting under local anesthesia. A urologist will insert a small delivery device through the urethra to access the enlarged prostate. Tiny UroLift implants are then deployed to retract the prostate tissue like curtain tie-backs. This opens up the urethra that was narrowed by the enlarged prostate. It typically takes only 30-45 minutes to place the implants.
UroLift stands out because it does not require any cutting, heating, or removal of prostate tissue. This means there is minimal risk of sexual side effects. Patients typically recover quickly with little downtime. Plus, it can provide rapid relief of symptoms like frequent/urgent urination within just 2-4 weeks.
Ideal candidates are men 45 years or older suffering from BPH symptoms. Their prostate size should be under 100cc. Patients who wish to preserve sexual function and want to avoid major surgery are often good candidates. Those with medical conditions that prevent undergoing general anesthesia may also benefit.
Most patients return home the same day with minimal downtime. Temporary side effects like pain or burning with urination are common initially. Over-the-counter medication can help with discomfort. Normal activities can usually be resumed within 2-3 days, though strenuous activity should be avoided for 1-2 weeks.
UroLift is covered by Medicare and many major insurance providers when medical criteria are met. Be sure to check your specific coverage. Out-of-pocket costs, if any, are usually comparable to other minimally invasive BPH procedures.